iSonea picks manufacturing partner for AirSonea
iSonea (ASX:ISN) has selected Hong Kong-based Refined Manufacturing to produce its AirSonea mobile wheeze monitoring device.
iSonea, which plans to launch the product in the Australian market in September, had already engaged Refined to produce several prototype AirSonea units. Refined will now scale up to prepare for commercial manufacturing.
“Finding a source with extensive experience and scalability to manufacture products that are smart-phone compatible was a crucial step in our transition to commercial production,” iSonea CEO Michael Thomas said.
AirSonea will allow patients to track and share acoustic respiratory monitoring data via smart phones.
Last week, iSonea released the results of a survey suggesting that 80% of Australian GPs surveyed would recommend AirSonea to their patients.
The company also recently unveiled AsthmaSense cloud, a cloud-based asthma monitoring tool.
iSonea shares were trading 8.11% higher at $0.40 as of around 1.30 pm on Wednesday.
Widespread resistance to common antibiotics is increasing: WHO
Increasing resistance to essential antibiotics poses a growing threat to global health, with one...
Dopamine helps our brains to let go of memories
In a discovery that could reshape how we think about memory, researchers at Flinders University...
Vaccine for elephant herpesvirus found to be safe
The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...
